Atlas Trials

A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS

Clinical trial NCT00002222 · COMPLETED

Trial details

NCT number
NCT00002222
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cytomegalovirus RetinitisHIV Infections
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.